Literature DB >> 2007702

Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris.

J C Kaski1, D Tousoulis, S Gavrielides, E McFadden, A R Galassi, F Crea, A Maseri.   

Abstract

It has been suggested that a generalized coronary vasomotion disorder is present in variant angina and that evaluation of baseline coronary artery tone may be useful for predicting the occurrence of coronary artery spasm. The vasomotor response of angiographically normal proximal and distal coronary artery segments was studied in 9 patients with atypical chest pain and normal coronary arteriograms (control group), 13 patients with active variant angina and 41 patients with chronic stable angina. Ergonovine (intravenous, 100 to 300 micrograms, or intracoronary, 8 to 20 micrograms, was administered to all 22 patients in the control and variant angina groups and to 11 of the 41 patients with chronic stable angina. All patients also received intracoronary isosorbide dinitrate (1 to 2 mg). Computerized coronary artery diameter measurement of angiographically normal segments was carried out before and after ergonovine and nitrate administration. Mean baseline intraluminal diameter of proximal and distal coronary segments was not significantly different in control patients and those with variant angina (nonspastic segments only) or coronary artery disease (proximal 2.89 +/- 0.15, 2.83 +/- 0.14 and 2.82 +/- 0.09 mm; distal 1.60 +/- 0.08, 1.63 +/- 0.07 and 1.62 +/- 0.06 mm, respectively). After ergonovine, proximal segments constricted by 10 +/- 2%, 15 +/- 3% and 11 +/- 4% and distal segments by 11 +/- 3%, 11 +/- 2% and 14 +/- 3% in control, variant angina and coronary artery disease groups, respectively (p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2007702     DOI: 10.1016/0735-1097(91)90830-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Increased platelet sodium-hydrogen exchanger activity in patients with variant angina.

Authors:  G A Lanza; E De Candia; E Romagnoli; L Messano; A Sestito; R Landolfi; F Crea; A Maseri
Journal:  Heart       Date:  2003-08       Impact factor: 5.994

2.  Conformational change in coronary artery structure assessed by optical coherence tomography in patients with vasospastic angina.

Authors:  Atsushi Tanaka; Kenei Shimada; Guillermo J Tearney; Hironori Kitabata; Haruyuki Taguchi; Shota Fukuda; Manabu Kashiwagi; Takashi Kubo; Shigeho Takarada; Kumiko Hirata; Masato Mizukoshi; Junichi Yoshikawa; Brett E Bouma; Takashi Akasaka
Journal:  J Am Coll Cardiol       Date:  2011-10-04       Impact factor: 24.094

3.  Evidence of partially preserved endothelial dilator function in diseased coronary arteries.

Authors:  D Tousoulis; C Tentolouris; T Crake; C Stefanadis; P Toutouzas; G Davies
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

4.  Changes of coronary blood flow in vasospastic angina under cold stimulation by transthoracic Doppler echocardiography.

Authors:  Seong Mi Park; Wan Joo Shim; Jung Cheon Ahn; Do Sun Lim; Young Hoon Kim; Young Moo Ro
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 5.  Coronary artery spasm: Current knowledge and residual uncertainties.

Authors:  Massimo Slavich; Riyaz Suleman Patel
Journal:  Int J Cardiol Heart Vasc       Date:  2016-01-23

Review 6.  MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Authors:  Lucas Lentini Herling de Oliveira; Vinícius Machado Correia; Pedro Felipe Gomes Nicz; Paulo Rogério Soares; Thiago Luis Scudeler
Journal:  J Clin Med       Date:  2022-09-20       Impact factor: 4.964

Review 7.  Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.

Authors:  Thomas J Ford; Peter Ong; Udo Sechtem; John Beltrame; Paolo G Camici; Filippo Crea; Juan-Carlos Kaski; C Noel Bairey Merz; Carl J Pepine; Hiroaki Shimokawa; Colin Berry
Journal:  JACC Cardiovasc Interv       Date:  2020-08-24       Impact factor: 11.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.